Immunohistochemical expression of EGF-R in malignant surface epithelial ovarian neoplasms (SEON).
EGF-R expression was found to be increased in 40% of malignant epithelial ovarian neoplasms by an immunohistochemical method. No correlation was found between EGF-R expression and clinical stage. There was a suggestion of reduced survival among tumours with positive EGF-R expression.
Janinis
J
J
St. Anargiri Cancer Hospital, Kifisia, Greece.
Nakopoulou
L
L
Panagos
G
G
Davaris
P
P
D000368:Aged; D002277:Carcinoma / Q000235:genetics / Q000473:pathology*; D018269:Carcinoma, Endometrioid / Q000235:genetics / Q000473:pathology; D002462:Cell Membrane / Q000648:ultrastructure; D003593:Cytoplasm / Q000648:ultrastructure; D004848:Epithelium / Q000473:pathology; D066246:ErbB Receptors / Q000032:analysis* / Q000235:genetics; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology*; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate
D066246:ErbB Receptors